The more affordable vials are marketed toward patients whose health insurance will not reimburse them for the cost of the drug.
Eli Lilly slashes price of weight-loss drug Zepbound by 50% to sell in smaller doses
The more affordable vials are marketed toward patients whose health insurance will not reimburse them for the cost of the drug.